Jun. 12 at 6:30 PM
$CUE Update
After a strong run from our
$20–
$22 entry point to a
$32 peak,
$CUE is experiencing a healthy pullback. This consolidation is a normal digestion phase for the stock.
Quick Stats
Previous Entry Zone:
$20–
$22
Recent High:
$32
Status: Healthy Pullback
What's coming up soon:
🔹Planned IND submission to the FDA to expand into food allergies (2H 2026).
🔹Upcoming results from the China Phase 2 CSU study.
With a strengthened balance sheet and a focus on transformative immunological therapies, the long-term thesis remains intact and the path for potential upside is clear for patient holders. Keep watching the setup.
Not financial advice. Trade your plan.
Communicated Disclaimer - https://stockresearchtoday.com/cue/
Other biotech's running up:
$UBXG $ANGH $BYAH
